Track the DIASORIN share price and the full management transaction log of the company, a listed issuer based in Italy. Shares are listed on the IT market, under the oversight of Consob. Operating in the Health Care sector, DIASORIN has published 0 public disclosures. Market capitalisation: €3.7bn. Every trade is free.
Analysts rate DIASORIN Hold (neutral), based on 14 analysts. Average price target: €72.45.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
DIASORIN is a company specializing in in vitro diagnostics, providing solutions for testing infectious diseases and other medical conditions. It is listed on the XMIL stock market.